| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $13.1M | +67.2% |
| SG&A Expense | $8.2M | +32.4% |
| Operating Income | -$21.3M | -51.9% |
| Pre-tax Income | -$19.3M | -41.7% |
| Income Tax | $43K | +53.6% |
| Net Income | -$19.4M | -41.7% |
| EPS (Basic) | -$0.60 | -15.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.5M | -3.9% |
| Short-term Investments | $48.4M | +68.0% |
| Accounts Receivable | $369K | +350.0% |
| Current Assets | $53.7M | +58.6% |
| Total Assets | $54.2M | +57.5% |
| Current Liabilities | $2.8M | +28.5% |
| Stockholders' Equity | $51.1M | +60.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.7M | -62.7% |
| Capital Expenditures | $24K | -70.4% |
| Investing Cash Flow | -$18.3M | -258.6% |
| Financing Cash Flow | $36.8M | — |
| Free Cash Flow | -$18.8M | -61.8% |